Analisi sito web parexel.com
CRO & Biopharmaceutical Services | Parexel
Generato il Marzo 07 2026 21:15 PM
Statistiche non aggiornate? AGGIORNA !
Il punteggio e 60/100
SEO Content
Title
CRO & Biopharmaceutical Services | Parexel
Lunghezza : 42
Perfetto, il tuo title contiene tra 10 e 70 caratteri.
Description
For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company. Learn more about how we can help.
Lunghezza : 129
Grande, la tua meta description contiene tra 70 e 160 caratteri.
Keywords
biopharmaceutical services
Buono, la tua pagina contiene meta keywords.
Og Meta Properties
Questa pagina non sfrutta i vantaggi Og Properties. Questi tags consentono ai social crawler di strutturare meglio la tua pagina. Use questo generatore gratuito di og properties per crearli.
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 2 | 51 | 8 | 32 | 0 |
- [H1] Who we are,
- [H2] While running a triathlon, Andrea stumbled and realized something was wrong.
- [H2] Parexel is proudly among the world’s largest clinical research organizations
- [H3] Solutions
- [H3] Portfolio management and asset valuation
- [H3] Early development and innovation
- [H3] Integrated clinical development
- [H3] Approval and access
- [H3] Value substantiation lifecycle management
- [H3] Operational excellence
- [H3] Biotech
- [H3] Therapeutic Expertise
- [H3] General medicine
- [H3] Infectious disease and vaccines
- [H3] Immunology
- [H3] Oncology
- [H3] Neuroscience
- [H3] Hematology
- [H3] Insights
- [H3] Participate
- [H3] Patient volunteers
- [H3] Sites
- [H3] About
- [H3] Leadership team
- [H3] Compliance, tax & privacy
- [H3] Solutions
- [H3] Portfolio management and asset valuation
- [H3] Early development and innovation
- [H3] Integrated clinical development
- [H3] Approval and access
- [H3] Value substantiation lifecycle management
- [H3] Operational excellence
- [H3] Biotech
- [H3] Therapeutic Expertise
- [H3] General medicine
- [H3] Infectious disease and vaccines
- [H3] Immunology
- [H3] Oncology
- [H3] Neuroscience
- [H3] Hematology
- [H3] Insights
- [H3] Participate
- [H3] Patient volunteers
- [H3] Sites
- [H3] About
- [H3] Leadership team
- [H3] Compliance, tax & privacy
- [H3] She thought it was just an injury. Her hamstrings were tight, and her body felt stiff and slow.
- [H3] She had ALS, a condition affecting more than 200,000 people around the world.
- [H3] Her life expectancy was shortened to just two to five years — but she was determined to make the most of it.
- [H3] Andrea continued to join triathlons, even as she underwent treatment in a clinical trial, inspiring many and raising $1,000,000 for ALS research.
- [H3] Today, alive beyond her original prognosis, she serves on our Patient Advisory Council, using her experiences to help improve our neuroscience trials.
- [H3] Lives can change when you design neuroscience trials with speed and precision.
- [H3] We focus on patients, because they inspire us to deliver better trials, faster than ever. So we can make a difference for more patients everywhere.
- [H4]
- [H4] Oncology
- [H4] I&I
- [H4] Cell & Gene Therapy
- [H4] Endocrine & Metabolic
- [H4] Resources
- [H4] Regional Websites
- [H4] Quick Links
- [H5] WHAT WE DO
- [H5] HOW WE DO IT
- [H5] PODCAST
- [H5] THERAPEUTIC EXPERTISE
- [H5] CROSS-THERAPEUTIC EXPERTISE
- [H5] RELATED INSIGHTS
- [H5] NEW MEDICINES, NOVEL INSIGHTS
- [H5] FEATURED INSIGHTS
- [H5] RECENT INSIGHTS
- [H5]
- [H5] Biopharm workforce report
- [H5] Powered by people
- [H5] INTERESTED IN PARTICIPATING?
- [H5] TRIAL SITES
- [H5] HEAR FROM REAL PATIENTS
- [H5] AWARD-WINNING-PARTNERS
- [H5] WHAT WE DO
- [H5] HOW WE DO IT
- [H5] PODCAST
- [H5] THERAPEUTIC EXPERTISE
- [H5] CROSS-THERAPEUTIC EXPERTISE
- [H5] RELATED INSIGHTS
- [H5] NEW MEDICINES, NOVEL INSIGHTS
- [H5] FEATURED INSIGHTS
- [H5] RECENT INSIGHTS
- [H5]
- [H5] Biopharm workforce report
- [H5] Powered by people
- [H5] INTERESTED IN PARTICIPATING?
- [H5] TRIAL SITES
- [H5] HEAR FROM REAL PATIENTS
- [H5] AWARD-WINNING-PARTNERS
Images
Abbiamo trovato 23 immagini in questa pagina web.
Buono, molte o tutte le tue immagini hanno attributo alt
Text/HTML Ratio
Ratio : 24%
Buono, il rapporto testo/codice HTML di questa pagina e maggiore di 15, e minore di 25 percento.
Flash
Perfetto, non e stato rilevato contenuto Flash in questa pagina.
Iframe
Molto male, hai usato Iframes nelle tue pagine web, questo significa che in contenuto inserito negli Iframe non puo essere indicizzato.
SEO Links
URL Rewrite
Buono. I tuoi links appaiono friendly!
Underscores in the URLs
Perfetto! Non sono stati rilevati underscores nei tuoi URLs.
In-page links
Abbiamo trovato un totale di 162 links inclusi 0 link(s) a files
| Anchor | Type | Juice |
|---|---|---|
| Solutions | Interno | Passing Juice |
| Portfolio management and asset valuation | Interno | Passing Juice |
| Early development and innovation | Interno | Passing Juice |
| Integrated clinical development | Interno | Passing Juice |
| Approval and access | Interno | Passing Juice |
| Value substantiation lifecycle management | Interno | Passing Juice |
| Delivery models | Interno | Passing Juice |
| Operational excellence | Interno | Passing Juice |
| Medical affairs | Interno | Passing Juice |
| Study start-up | Interno | Passing Juice |
| Overview | Interno | Passing Juice |
| Building patient insights into assets, profile and claims | Interno | Passing Juice |
| Portfolio optimization | Interno | Passing Juice |
| Asset valuation and indication prioritization | Interno | Passing Juice |
| Early evidence review | Interno | Passing Juice |
| Integrated development strategy and planning | Interno | Passing Juice |
| Phase I Clinical Trials | Interno | Passing Juice |
| Site Alliance Network and KOL Engagement | Interno | Passing Juice |
| Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) | Interno | Passing Juice |
| Regulatory Strategy | Interno | Passing Juice |
| Real World Evidence | Interno | Passing Juice |
| Market Access Consulting, Strategy, and Delivery | Interno | Passing Juice |
| Biomarker and Genomic Medicine Strategy | Interno | Passing Juice |
| Integrated evidence generation planning | Interno | Passing Juice |
| Medical Communications | Interno | Passing Juice |
| Phase IIB-IV Clinical Trials | Interno | Passing Juice |
| Real World Evidence | Interno | Passing Juice |
| Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) | Interno | Passing Juice |
| Protocol-Driven, Customized Site Solution Strategy | Interno | Passing Juice |
| Patient Inclusion | Interno | Passing Juice |
| Regulatory Strategy, Submissions, Compliance, and Outsourcing | Interno | Passing Juice |
| Market Access Strategy and Delivery | Interno | Passing Juice |
| Clinical Development Technology Optimization | Interno | Passing Juice |
| Clinical Trial Supply & Logistics | Interno | Passing Juice |
| Integrated evidence generation planning | Interno | Passing Juice |
| Medical Communications | Interno | Passing Juice |
| Drug Safety and Pharmacovigilance | Interno | Passing Juice |
| Global Regulatory Submissions and Outsourcing | Interno | Passing Juice |
| Real World Evidence | Interno | Passing Juice |
| Compliance and Risk Management | Interno | Passing Juice |
| Market Access Strategy and Delivery | Interno | Passing Juice |
| Integrated evidence generation planning | Interno | Passing Juice |
| Medical Communications | Interno | Passing Juice |
| Drug Safety and Pharmacovigilance | Interno | Passing Juice |
| Health economics modelling and simulation | Interno | Passing Juice |
| Real-World Evidence, Market Access Strategy and Planning | Interno | Passing Juice |
| Regulatory Compliance | Interno | Passing Juice |
| Lifecycle Optimization | Interno | Passing Juice |
| Integrated evidence generation planning | Interno | Passing Juice |
| Medical Communications | Interno | Passing Juice |
| Gain an advantage through FSP | Interno | Passing Juice |
| Leveraging AI in clinical development | Interno | Passing Juice |
| Medical affairs for clinical trials | Interno | Passing Juice |
| Biotech | Interno | Passing Juice |
| Listen Now | Interno | Passing Juice |
| Therapeutic Expertise | Interno | Passing Juice |
| Neuroscience | Interno | Passing Juice |
| General medicine | Interno | Passing Juice |
| Infectious disease and vaccines | Interno | Passing Juice |
| Immunology | Interno | Passing Juice |
| Oncology | Interno | Passing Juice |
| Hematology | Interno | Passing Juice |
| Cell and gene therapies | Interno | Passing Juice |
| Pediatrics | Interno | Passing Juice |
| Rare diseases | Interno | Passing Juice |
| Overview | Interno | Passing Juice |
| Cell and gene therapy | Interno | Passing Juice |
| Gastroenterology CRO | Interno | Passing Juice |
| Respiratory CRO | Interno | Passing Juice |
| Endocrine & Metabolic CRO | Interno | Passing Juice |
| Cardiovascular CRO | Interno | Passing Juice |
| Women's health CRO | Interno | Passing Juice |
| Critical Care | Interno | Passing Juice |
| Hepatitis B | Interno | Passing Juice |
| Novel treatments in infectious disease | Interno | Passing Juice |
| Ophthalmology CRO | Interno | Passing Juice |
| Dermatology CRO | Interno | Passing Juice |
| Allergy CRO | Interno | Passing Juice |
| Bladder cancer CRO | Interno | Passing Juice |
| Breast cancer CRO | Interno | Passing Juice |
| Gynecologic cancer CRO | Interno | Passing Juice |
| Head and neck cancer CRO | Interno | Passing Juice |
| Lung cancer CRO | Interno | Passing Juice |
| Phase I and rare tumors | Interno | Passing Juice |
| Prostate cancer CRO | Interno | Passing Juice |
| Neurology | Interno | Passing Juice |
| Psychiatry | Interno | Passing Juice |
| Pediatrics | Interno | Passing Juice |
| Rare Diseases | Interno | Passing Juice |
| Lymphoma CRO | Interno | Passing Juice |
| Acute myelogenous leukemia (AML) CRO | Interno | Passing Juice |
| Myelodysplastic syndrome (MDS) CRO | Interno | Passing Juice |
| Multiple Myeloma CRO | Interno | Passing Juice |
| Learn more | Interno | Passing Juice |
| Learn more | Interno | Passing Juice |
| Insights | Interno | Passing Juice |
| New frontiers in neuroscience | Interno | Passing Juice |
| Precision oncology | Interno | Passing Juice |
| Rare disease drug development | Interno | Passing Juice |
| Cell and gene therapy development | Interno | Passing Juice |
| Patient-guided drug development | Interno | Passing Juice |
| Clinical Trialblazers Podcast | Interno | Passing Juice |
| The Regulatory Navigator | Interno | Passing Juice |
| On The Pulse | Interno | Passing Juice |
| Learn more | Interno | Passing Juice |
| Learn more | Interno | Passing Juice |
| Participate | Interno | Passing Juice |
| Healthy volunteers | Interno | Passing Juice |
| Patient volunteers | Interno | Passing Juice |
| Patient advocacy groups | Interno | Passing Juice |
| Baltimore | Externo | Passing Juice |
| Los Angeles | Externo | Passing Juice |
| London | Externo | Passing Juice |
| Berlin | Externo | Passing Juice |
| Overview | Interno | Passing Juice |
| Advisory Council | Interno | Passing Juice |
| Patient stories | Interno | Passing Juice |
| Andrea & David's Story | Interno | Passing Juice |
| Stacy's Story | Interno | Passing Juice |
| Anisha's Story | Interno | Passing Juice |
| Rob's Story | Interno | Passing Juice |
| Learn more | Interno | Passing Juice |
| Sites | Interno | Passing Juice |
| Learn more | Interno | Passing Juice |
| About | Interno | Passing Juice |
| Leadership team | Interno | Passing Juice |
| Global reach | Interno | Passing Juice |
| Our inclusion strategy | Interno | Passing Juice |
| Our ESG strategy | Interno | Passing Juice |
| Compliance, tax & privacy | Interno | Passing Juice |
| Meet us at an event | Interno | Passing Juice |
| Overview | Interno | Passing Juice |
| Board of Directors | Interno | Passing Juice |
| Our ESG strategy | Interno | Passing Juice |
| Compliance & Ethics | Interno | Passing Juice |
| Tax Strategy | Interno | Passing Juice |
| Privacy Policy | Interno | Passing Juice |
| Cookies and other web tracking | Interno | Passing Juice |
| Supplier Data Privacy Requirements | Interno | Passing Juice |
| Terms of Use | Interno | Passing Juice |
| French Gender Pay Data | Interno | Passing Juice |
| UK Gender Pay Data | Interno | Passing Juice |
| UK Modern Slavery Act Statement | Interno | Passing Juice |
| Ireland Gender Pay Data | Interno | Passing Juice |
| Supplier Inclusion Policy | Interno | Passing Juice |
| Newsroom | Interno | Passing Juice |
| Academy | Externo | Passing Juice |
| Careers | Interno | Passing Juice |
| 中国 (China) | Interno | Passing Juice |
| 日本 (Japan) | Interno | Passing Juice |
| Contact Us | Interno | Passing Juice |
| Oncology | Interno | Passing Juice |
| Immunology | Interno | Passing Juice |
| Cell & Gene Therapy | Interno | Passing Juice |
| Endocrine & Metabolic | Interno | Passing Juice |
| See neuroscience capabilities | Interno | Passing Juice |
| Explore neuroscience careers | Interno | Passing Juice |
| biopharmaceutical leaders and sites | Interno | Passing Juice |
| Contact us | Interno | Passing Juice |
| My Communication Preferences | Interno | Passing Juice |
| Invoicing | Interno | Passing Juice |
| PO Terms and Conditions | Interno | Passing Juice |
SEO Keywords
Keywords Cloud
clinical medical access overview development trials patient cro strategy more
Consistenza Keywords
| Keyword | Contenuto | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| clinical | 55 |  |
|
|
 |
| cro | 50 | |
|
|
|
| overview | 44 | |
|
|
|
| development | 36 | |
|
|
|
| strategy | 30 | |
|
|
|
Usabilita
Url
Dominio : parexel.com
Lunghezza : 11
Favicon
Grande, il tuo sito usa una favicon.
Stampabilita
Non abbiamo riscontrato codice CSS Print-Friendly.
Lingua
Buono. La tua lingua dichiarata en.
Dublin Core
Questa pagina non sfrutta i vantaggi di Dublin Core.
Documento
Doctype
HTML 5
Encoding
Perfetto. Hai dichiarato che il tuo charset e UTF-8.
Validita W3C
Errori : 0
Avvisi : 0
Email Privacy
Grande. Nessun indirizzo mail e stato trovato in plain text!
Deprecated HTML
Grande! Non abbiamo trovato tags HTML deprecati nel tuo codice.
Suggerimenti per velocizzare
|
Eccellente, il tuo sito web non utilizza nested tables. |
|
Molto male, il tuo sito web utilizza stili CSS inline. |
|
Molto male, il tuo sito web ha troppi file CSS files (piu di 4). |
|
Molto male, il tuo sito web ha troppi file JS (piu di 6). |
|
Perfetto, il vostro sito si avvale di gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Ottimizzazione
XML Sitemap
Grande, il vostro sito ha una sitemap XML.
| https://www.parexel.com/sitemap.xml |
Robots.txt
https://parexel.com/robots.txt
Grande, il vostro sito ha un file robots.txt.
Analytics
Non trovato
Non abbiamo rilevato uno strumento di analisi installato su questo sito web.
Web analytics consentono di misurare l'attività dei visitatori sul tuo sito web. Si dovrebbe avere installato almeno un strumento di analisi, ma può anche essere buona per installare una seconda, al fine di un controllo incrociato dei dati.
PageSpeed Insights
Dispositivo
Categorie
Free SEO Testing Tool
Free SEO Testing Tool e uno strumento di ottimizzazione per i motori di ricerca (seo tool) che serve per analizzare le tue pagine web